RedHill Biopharma Ltd. financial data

Symbol
RDHL on Nasdaq
Location
21 Ha'arba'a Street, Tel Aviv, Israel
State of incorporation
Israel
Latest financial report
20-F - Q4 2023 - Apr 8, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.7B shares +981%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 1.47M USD -85.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 23M USD -85.5%
Liabilities 21M USD -89.9%